Encompass Health Corporation
US ˙ NYSE ˙ US29261A1007

SecurityEHC / Encompass Health Corporation
InsiderTerrance Williams
This page shows the track record and history of Williams Terrance insider trades in Encompass Health Corporation. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Terrance Williams in EHC / Encompass Health Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2021-12-02 354 56.6100 445 45.0358 20,040 133 74.2800 12,941 64.58

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

EHC / Encompass Health Corporation Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Terrance Williams in EHC / Encompass Health Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

EHC / Encompass Health Corporation Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2026-05-11 2026-05-07 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 1,634 16,830
2026-04-16 2026-04-15 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 27 15,196
2026-01-16 2026-01-15 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 28 15,169
2025-10-16 2025-10-15 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 23 15,141
2025-07-16 2025-07-15 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 24 15,118
2025-05-02 2025-05-01 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 1,424 15,094
2025-04-16 2025-04-15 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 23 13,670
2025-01-17 2025-01-15 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 25 13,647
2024-10-17 2024-10-15 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 24 13,622
2024-07-17 2024-07-15 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 24 13,598
2024-05-03 2024-05-02 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 1,978 13,574
2024-04-16 2024-04-15 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 21 11,596
2024-01-17 2024-01-16 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 24 11,575
2023-10-17 2023-10-16 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 27 11,551
2023-07-18 2023-07-17 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 25 11,524
2023-05-08 2023-05-04 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 2,385 11,499
2023-04-19 2023-04-17 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 22 9,114
2023-01-19 2023-01-17 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 22 9,092
2022-10-19 2022-10-17 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 27 9,070
2022-07-21 2022-07-20 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 50 7,577
2022-05-09 2022-05-05 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 2,226 7,527
2022-04-20 2022-04-18 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 20 5,301
2022-01-20 2022-01-18 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 23 5,281
2021-12-02 2021-12-02 4 Williams Terrance EHC Encompass Health Common Stock P - Purchase D 56.6100 354 20 5,258
2021-10-19 2021-10-15 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 21 4,904
2021-07-16 2021-07-15 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 18 4,883
2021-05-10 2021-05-06 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 1,757 4,865
2021-04-19 2021-04-15 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 11 3,108
2021-01-20 2021-01-19 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 11 3,097
2020-10-20 2020-10-16 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 13 3,086
2020-07-20 2020-07-16 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 14 3,073
2020-05-07 2020-05-06 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 2,304 3,059
2020-04-17 2020-04-15 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 4 755
2020-01-21 2020-01-16 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 3 751
2020-01-02 2020-01-02 4 Williams Terrance EHC Encompass Health Common Stock A - Award D 748 748
P
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매입
S
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매각
A
자사로부터 유가증권(옵션 등)을 보조, 지급 또는 기타 취득
C
파생상품 전환
D
자사에게 유가증권을 매각 또는 양도
F
기업으로부터 인도 받은 유가증권의 일부를 사용한 행사 가격 또는 조세 채무의 지급
G
내부자에 의한 또는 내부자에게 증권 증여
K
지분스왑 및 유사 위험 회피거래
M
자사로부터 인도 받은 파생증권(옵션 등)의 행사 또는 전환
V
보고서 양식 4에 자진 신고된 거래
J
기타 (거래 내용을 설명하는 각주와 동반)